Bram Vanparys

KBC AM is an active manager which invests in equity and fixed-income without following any particular investment style. They are also a passive manager for certain asset classes or portfolios. Within the group, the firm defines the investment strategy and undertakes a large part of the group's investment product development. They are also a competence center, contributing the bulk of the group's economic research. Research teams combine in-house research with outsourced investment intelligence to obtain risk estimates for all asset classes in which the firm invests. KBC AM’s investment process is primarily top-down. They first seek to identify market trends, then tactically allocate assets within a previously defined strategic framework and construct portfolios, aided by a qualitative bottom-up overlay.

PMV invests in companies located in Belgium. The firm focuses on a broad range of sectors and industries. It participates in equity and debt in seed stage, early stage, late stage and growth stage transactions with an investment size up to EUR 20 million. It consider minority investments and also makes co-investments.

Gimv invests in small and middle market companies located in Benelux region and France. The firm focuses on sectors such as consumer, healthcare, smart industries and sustainable cities. It participates in growth stage capital requirements with an investment size of EUR 5 - 75 million.

Functions as a College/University

KBC Private Equity is an active, long-term manager which typically invests between €2 million and €50 million in medium-sized unlisted companies primarily in Belgium, Central and Eastern Europe. The firm targets performing businesses in diverse sectors which usually demonstrate a positive EBITDA of at least €1.5 million, focusing on companies which have built up a leading position in a specific sector and which have identified growth opportunities. Specific criteria apply for investments in the biotech industry. The firm takes both majority and minority interests in companies, partnering with the other shareholders and investee company management. In addition to providing equity and/or mezzanine financing, they aim to create value in areas where they are skilled, without participating in the day-to-day operational policy of the investee company. KBC Private Equity generally seeks a seat on the Board of Directors. The firm aims to contribute to investee companies by evaluating their internal and external growth opportunities, optimizing their financial structure, introducing new customer and supplier relationships, improving reporting systems and sharing specific industry knowledge. Their typical holding period is five to seven years for most of their investment projects.

Functions as a College/University

Functions as a private equity fund

Provides software and database systems to genetic labs and clinicians

Operates a quality management system to design, develop, manufacture and distribute CE-IVD products